ProfileGDS4718 / 219303_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 73% 74% 86% 69% 74% 89% 89% 81% 70% 76% 75% 78% 86% 94% 90% 73% 79% 93% 86% 71% 77% 80% 78% 73% 76% 91% 76% 92% 75% 92% 84% 91% 74% 74% 91% 92% 87% 81% 75% 86% 73% 92% 85% 92% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.1547973
GSM549102patient 115, normal, homogenized [OPG study]7.1733974
GSM549104patient 119, normal, homogenized [OPG study]8.6091286
GSM549108patient 138, normal, homogenized [OPG study]6.7931469
GSM549119patient 077, normal, homogenized [OPG study]7.1708274
GSM549133patient 032, cancer, homogenized [OPG study]9.1170489
GSM549139patient 042, cancer, homogenized [OPG study]9.041189
GSM549099patient 107, normal, homogenized [OPG study]7.8896581
GSM549109patient 139, normal, homogenized [OPG study]6.8612270
GSM549110patient 046, normal, homogenized [OPG study]7.4354176
GSM549114patient 063, normal, homogenized [OPG study]7.3864675
GSM549122patient 082, normal, homogenized [OPG study]7.6622378
GSM549134patient 033, cancer, homogenized [OPG study]8.674686
GSM549136patient 036, cancer, homogenized [OPG study]10.082994
GSM549140patient 044, cancer, homogenized [OPG study]9.2430690
GSM549111patient 047, normal, homogenized [OPG study]7.1327573
GSM549113patient 057, normal, homogenized [OPG study]7.878179
GSM549132patient 031, cancer, homogenized [OPG study]9.7038893
GSM549137patient 038, cancer, homogenized [OPG study]8.6091586
GSM549142patient 047, cancer, homogenized [OPG study]6.9448171
GSM549100patient 110, normal, homogenized [OPG study]7.5042177
GSM549107patient 135, normal, homogenized [OPG study]7.8421180
GSM549115patient 068, normal, homogenized [OPG study]7.7583378
GSM549116patient 072, normal, homogenized [OPG study]7.2104373
GSM549120patient 078, normal, homogenized [OPG study]7.4372976
GSM549131patient 030, cancer, homogenized [OPG study]9.4093191
GSM549118patient 074, normal, homogenized [OPG study]7.4790976
GSM549129patient 027, cancer, homogenized [OPG study]9.3700292
GSM549123patient 088, normal, homogenized [OPG study]7.3270275
GSM549124patient 006, cancer, homogenized [OPG study]9.3271592
GSM549126patient 015, cancer, homogenized [OPG study]8.2844984
GSM549128patient 025, cancer, homogenized [OPG study]9.3501591
GSM549103patient 117, normal, homogenized [OPG study]7.1636474
GSM549117patient 073, normal, homogenized [OPG study]7.2255974
GSM549138patient 041, cancer, homogenized [OPG study]9.4120691
GSM549141patient 045, cancer, homogenized [OPG study]9.6015892
GSM549130patient 028, cancer, homogenized [OPG study]8.6366387
GSM549101patient 111, normal, homogenized [OPG study]7.9103281
GSM549105patient 128, normal, homogenized [OPG study]7.2658175
GSM549106patient 134, normal, homogenized [OPG study]8.8188786
GSM549112patient 048, normal, homogenized [OPG study]7.1555773
GSM549125patient 011, cancer, homogenized [OPG study]9.4582792
GSM549127patient 024, cancer, homogenized [OPG study]8.3962385
GSM549135patient 035, cancer, homogenized [OPG study]9.6077992